Patent Assignment
Reel/Frame 058873/0772
Assignment of Assignor's Interest
Recorded: 2022-02-03
Pages: 5
Assignor
ALKERMES, INC.
Executed: 2022-02-02
Assignee
ALKERMES PHARMA IRELAND LIMITED
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Properties
(10)
Ligands Modified by Circular Permutation as Agonists and Antagonists
Ligands Modified by Circular Permutation as Agonists and Antagonists
Ligands Modified by Circular Permutation as Agonists and Antagonists
Ligands Modified by Circular Permutation as Agonists and Antagonists
Application:
16/519,231 →
Publication:
US 2020/0040053
Fusion Polypeptides Comprising an Active Protein Linked to a Mucin-Domain Polypeptide
Application:
61/657,264 →
Fusion Polypeptides Comprising Mucin-Domain Polypeptide Linkers
Application:
61/657,285 →
Ligands Modified by Circular Permutation as Agonists and Antagonists
Application:
61/657,378 →
Ligands Modified by Circular Permutation as Agonists and Antagonists
Application:
61/723,081 →
Fusion Polypeptides Comprising an Active Protein Linked to a Mucin-Domain Polypeptide
Application:
61/778,575 →
Fusion Polypeptides Comprising Mucin-Domain Polypeptide Linkers
Application:
61/778,812 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 18, 2012
From: ALVAREZ, JUAN; MCSWEENEY, LESLIE A.
To: ALKERMES, INC.
Reel/Frame 028580/0147 →
Assignment of Assignor's Interest
Jul 18, 2012
From: ALVAREZ, JUAN; CHAMOUN, JEAN
To: ALKERMES, INC.
Reel/Frame 028580/0121 →
Assignment of Assignor's Interest
Jul 18, 2012
From: ALVAREZ, JUAN; CHAMOUN, JEAN; LOSEY, HEATHER C.
To: ALKERMES, INC.
Reel/Frame 028579/0990 →
Assignment of Assignor's Interest
Feb 7, 2013
From: ALVAREZ, JUAN; CHAMOUN, JEAN
To: ALKERMES, INC.
Reel/Frame 029770/0194 →
Assignment of Assignor's Interest
Aug 16, 2013
From: ALVAREZ, JUAN; CHAMOUN, JEAN
To: ALKERMES, INC.
Reel/Frame 031026/0325 →
Assignment of Assignor's Interest
Oct 3, 2013
From: ALVAREZ, JUAN; CHAMOUN, JEAN
To: ALKERMES, INC.
Reel/Frame 031337/0093 →
Security Interest
Jun 25, 2014
From: ALKERMES, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 033244/0499 →
Security Interest
May 3, 2018
From: ALKERMES, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 045711/0636 →
Corrective Assignment to Correct to Remove Patent Number from 9,428,567 to 9,428,563 Previously Recorded at Reel: 040672 Frame: 0529. Assignor(S) Hereby Confirms the Security Interest.
May 3, 2018
From: ALKERMES, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047231/0346 →
Security Interest
Mar 20, 2020
From: ALKERMES, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 052174/0842 →
Release of Security Interest
Nov 21, 2023
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 065637/0466 →
Assignment of Assignor's Interest
Jun 27, 2024
From: ALVAREZ, JUAN
To: ALKERMES, INC.
Reel/Frame 067857/0912 →
Assignment of Assignor's Interest
Jun 27, 2024
From: ALKERMES PLC
To: MURAL ONCOLOGY, INC.
Reel/Frame 067858/0785 →
Assignment of Assignor's Interest
Jun 27, 2024
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PLC
Reel/Frame 067858/0665 →
Release of Patent Security Agreements
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.
Reel/Frame 069771/0616 →